Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
Location: Germany, Brandenburg, Hennigsdorf
Employees: 11-50
Total raised: $24.1M
Founded date: 2002
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.10.2018 | - | $24.1M | Wellington... |
Mentions in press and media 20
| Date | Title | Description |
| 04.05.2026 | Brandenburg Kapital - News about SphingoTec GmbH | Hennigsdorf – October 2024. Diagnostic company SphingoTec GmbH (“SphingoTec”) today announced a new licensing partnership with Beckman Coulter Diagnostics Inc. (“Beckman Coulter”). Through this collaboration, the companies will bring an ass... |
| 26.11.2022 | Brandenburg Kapital - News about SphingoTec GmbH | Hennigsdorf – November 2022. Boditech Med Inc., a globally leading diagnostics company from Korea,announced its first global licensing agreement with SphingoTec for its highly innovative kidney function marker penKid. |
| 26.08.2022 | Interdepartmental Testing of the Kidney Function Biomarker PenKid in Routine Care at Heidelberg University Hospital and the Heidelberg Kidney Center | Acute kidney injury (AKI) is a complex syndrome, which results in a rapid loss of kidney function, affecting 1 in 5 patients (1) during hospitalization. Four units at the University Hospital Heidelberg and Heidelberg Kidney Center implement... |
| 26.08.2022 | Interdepartmental Testing of the Kidney Function Biomarker PenKid in Routine Care at Heidelberg University Hospital and the Heidelberg Kidney Center | Acute kidney injury (AKI) is a complex syndrome, which results in a rapid loss of kidney function, affecting 1 in 5 patients (1) during hospitalization. Four units at the University Hospital Heidelberg and Heidelberg Kidney Center implement... |
| 11.04.2022 | Biomarker-Guided Trial Led by University Hospital Hamburg-Eppendorf (UKE) Opens New Avenues for Personalized Medicine in COVID-19 | A multi-center study led by UKE is evaluating one of the first personalized approaches for moderate to severe COVID-19 patients. The innovative biomarkers bio-ADM and DPP3 are guiding the enrollment of patients suffering from endothelial ba... |
| 29.03.2022 | Brandenburg Kapital - News about SphingoTec GmbH | Hennigsdorf – March 2022. Rivaara Labs, one of the leading providers of molecular diagnostics and point-of-care technologies in India, has been granted exclusive rights by SphingoTec to market and distribute the Nexus IB10 platform and its ... |
| 29.11.2021 | SphingoTec Appoints Jörg Menten to Leadership Team as Chief Commercial Officer to Drive New Business Growth | DGAP-News: SphingoTec GmbH / Key word(s): Corporate Action/Personnel SphingoTec Appoints Jörg Menten to Leadership Team as Chief Commercial Officer to Drive New Business Growth 29.11.2021 / 10:00 The issuer is solely responsible for the con... |
| 09.09.2021 | SphingoTec GmbH : innovative biomarkers to enable personalized medicine in septic organ failure | DGAP-News: SphingoTec GmbH / Key word(s): Conference/Study results SphingoTec's innovative biomarkers to enable personalized medicine in septic organ failure 09.09.2021 / 10:00 The issuer is solely responsible for the content of this announ... |
| 23.08.2021 | SphingoTec GmbH : Appoints Dr. Gerald Möller as Chairman of the Advisory Board | DGAP-News: SphingoTec GmbH / Key word(s): Strategic Company Decision/Personnel SphingoTec Appoints Dr. Gerald Möller as Chairman of the Advisory Board 23.08.2021 / 10:00 The issuer is solely responsible for the content of this announcement.... |
| 10.06.2021 | SphingoTec GmbH : Expands Management Team and Appoints new CFO | DGAP-News: SphingoTec GmbH / Key word(s): Corporate Action/Strategic Company Decision SphingoTec Expands Management Team and Appoints new CFO 10.06.2021 / 10:00 The issuer is solely responsible for the content of this announcement. Dr. Ange... |
Show more